Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...
The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma ...
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)
Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for ...
Zee Business16d
Glenmark Pharma launches Acetylcysteine injection in US; long-term positive?
Glenmark Pharma Share Price News: Mumbai-headquartered pharmaceuticals company Glenmark Pharma's shares are in the spotlight once again on Dalal Street.The company's US arm has released its injection ...
Daily16d
Glenmark US arm recalls 15 lakh bottles of ADHD medication in US
New Delhi: Glenmark Pharmaceuticals Inc, USA, an arm of the Mumbai-based Glenmark Pharmaceuticals, is recalling around 14.76 lakh bottles of Atomoxetine Capsules in multiple strengths in the US market ...
Business Standard17d
Glenmark Pharma gains after arm launches Acetylcysteine injection
Glenmark Pharmaceuticals added 1.06% to Rs 1292.35 after the US-based subsidiary, Glenmark Pharmaceuticals Inc., USA announced the acquisition and launched of Acetylcysteine Injection, single-dose ...
Longview News-Journal17d
Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...
The Financial Express18d
Glenmark recalls 15 lakh bottles of ADHD medication due to ‘CGMP Deviations’ in United States
Pharma major Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market. According to ...